Abbott clinical biochemical immunoglobulin A test group
Taiwan·Risk Class 2·Made (部分製程) in JAPAN;; ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Jan 14, 2022 – Jan 14, 2027Active- Analysis ID
- 7fb956a77a78a167fd0805dcf8d3f375
- Customs Code
- DHA05603520501
- Manufacturer Country
- Ireland;;Japan
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used to quantify IgA in human serum or plasma on the ARCHITECT c system.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
- Import Information
- Input;; QMS/QSD
- Registration Date
- Jan 14, 2022
- Expiry Date
- Jan 14, 2027
Top companies providing products similar to "Abbott clinical biochemical immunoglobulin A test group"
Recently registered similar products
Access comprehensive regulatory information for Abbott clinical biochemical immunoglobulin A test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7fb956a77a78a167fd0805dcf8d3f375 and manufactured by Made (部分製程) in JAPAN;; ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.